|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Crystal structure of aurora a in complex with vx-680 and tpx2
|
|
Structure:
|
 |
Serine/threonine-protein kinase 6. Chain: a. Fragment: residues 122-403. Synonym: aurora kinase a, aurora-a, serine/threonine kinase 15, aurora/ipl1-related kinase 1, aurora-related kinase 1, hark1, breast tumor-amplified kinase. Engineered: yes. Targeting protein for xklp2. Chain: b.
|
|
Source:
|
 |
Homo sapiens. Organism_taxid: 9606. Gene: aurka, aik, ark1, aura, btak, stk15, stk6. Expressed in: escherichia coli. Gene: tpx2, c20orf1, c20orf2, dil2, hca519.
|
|
Resolution:
|
 |
|
2.30Å
|
R-factor:
|
0.206
|
R-free:
|
0.256
|
|
|
Authors:
|
 |
B.Zhao,A.Smallwood,Z.Lai
|
Key ref:
|
 |
B.Zhao
et al.
(2008).
Modulation of kinase-inhibitor interactions by auxiliary protein binding: crystallography studies on Aurora A interactions with VX-680 and with TPX2.
Protein Sci,
17,
1791-1797.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
13-Aug-08
|
Release date:
|
28-Oct-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chain A:
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Protein Sci
17:1791-1797
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Modulation of kinase-inhibitor interactions by auxiliary protein binding: crystallography studies on Aurora A interactions with VX-680 and with TPX2.
|
|
B.Zhao,
A.Smallwood,
J.Yang,
K.Koretke,
K.Nurse,
A.Calamari,
R.B.Kirkpatrick,
Z.Lai.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
VX-680, also known as MK-0457, is an ATP-competitive small molecule inhibitor of
the Aurora kinases that has entered phase II clinical trials for the treatment
of cancer. We have solved the cocrystal structure of AurA/TPX2/VX-680 at 2.3 A
resolution. In the crystal structure, VX-680 binds to the active conformation of
AurA. The glycine-rich loop in AurA adopts a unique bent conformation, forming a
pi-pi interaction with the phenyl group of VX-680. In contrast, in the published
AurA/VX-680 structure, VX-680 binds to AurA in the inactive conformation,
interacting with a hydrophobic pocket only present in the inactive conformation.
These data suggest that TPX2, a protein cofactor, can alter the binding mode of
VX-680 with AurA. More generally, the presence of physiologically relevant
cofactor proteins can alter the kinetics, binding interactions, and inhibition
of enzymes, and studies with these multiprotein complexes may be beneficial to
the discovery and optimization of enzyme inhibitors as therapeutic agents.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Binding of VX-680 in the active site of AurA/TPX2. (A) The
electron density of VX-680 contoured at 1.5[sigma] from the
final 2fo-fc map. The AurA carbons are shown in green, inhibitor
carbons in yellow, oxygens in red, nitrogens in blue, sulfur in
orange, and water molecules in light blue. (B) Interactions of
VX-680 with the active site of AurA when TPX2 is bound. The
backbone tracing is in gray and hydrogen bonds are shown as
dotted black lines. (C) Interactions of VX-680 with the active
site of AurA without TPX2 bound (adapted from Cheetham et al.
2007 and reprinted with permission from Elsevier
[copyright]2007).
|
 |
Figure 3.
Superposition of the backbones of AurA/TPX2/VX-680 (gold) and
AurA/TPX2/ADP (gray, pdb: 1ol5) structures focusing on the
different conformations of the glycine-rich loop. The C[alpha]
of Phe144^AUR in the AurA/TPX2/VX-680 structure has moved by >8
A. The VX-680 carbons are in yellow, the ADP carbons in green,
oxygens in red, nitrogens in blue, sulfur and phosphorus in
orange. The side chain of Phe144 is shown in stick form.
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by the Protein Society:
Protein Sci
(2008,
17,
1791-1797)
copyright 2008.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Yan,
L.Wang,
S.Xu,
and
J.Xu
(2011).
Aurora-A kinase inhibitor scaffolds and binding modes.
|
| |
Drug Discov Today,
16,
260-269.
|
 |
|
|
|
|
 |
X.Xu,
X.Wang,
Z.Xiao,
Y.Li,
and
Y.Wang
(2011).
Two TPX2-Dependent Switches Control the Activity of Aurora A.
|
| |
PLoS One,
6,
e16757.
|
 |
|
|
|
|
 |
Y.Lei,
S.Yan,
L.Ming-De,
L.Na,
and
H.Rui-Fa
(2011).
Prognostic significance of Aurora-A expression in human bladder cancer.
|
| |
Acta Histochem,
113,
514-518.
|
 |
|
|
|
|
 |
K.Anderson,
Z.Lai,
O.B.McDonald,
J.D.Stuart,
E.N.Nartey,
M.A.Hardwicke,
K.Newlander,
D.Dhanak,
J.Adams,
D.Patrick,
R.A.Copeland,
P.J.Tummino,
and
J.Yang
(2009).
Biochemical characterization of GSK1070916, a potent and selective inhibitor of Aurora B and Aurora C kinases with an extremely long residence time1.
|
| |
Biochem J,
420,
259-265.
|
 |
|
|
|
|
 |
P.J.Scutt,
M.L.Chu,
D.A.Sloane,
M.Cherry,
C.R.Bignell,
D.H.Williams,
and
P.A.Eyers
(2009).
Discovery and exploitation of inhibitor-resistant aurora and polo kinase mutants for the analysis of mitotic networks.
|
| |
J Biol Chem,
284,
15880-15893.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |